A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
| Status: | Completed |
|---|---|
| Conditions: | Ovarian Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/24/2018 |
| Start Date: | July 2001 |
| End Date: | February 16, 2018 |
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
The purpose of the research is to determine if blood tests and a CT scan done before surgery
can predict how successful the surgery will be. In patients who have cancer of the ovary that
has spread, it is hoped that the CT scan will be able to identify the various places where
the cancer has spread so that additional surgeons can be available to help with the surgical
procedure.
If you have confirmed stage 3 or 4 ovarian, fallopian tube, or primary peritoneal cancer, you
may undergo a CT scan of the abdomen and pelvis after the surgery to compare how much cancer
the surgeon thought was left after surgery to what is seen on CT scan. A CT scan of the chest
will be done if your physician thinks it is necessary.
can predict how successful the surgery will be. In patients who have cancer of the ovary that
has spread, it is hoped that the CT scan will be able to identify the various places where
the cancer has spread so that additional surgeons can be available to help with the surgical
procedure.
If you have confirmed stage 3 or 4 ovarian, fallopian tube, or primary peritoneal cancer, you
may undergo a CT scan of the abdomen and pelvis after the surgery to compare how much cancer
the surgeon thought was left after surgery to what is seen on CT scan. A CT scan of the chest
will be done if your physician thinks it is necessary.
This study is designed to assess the utility and impact of computed tomography (CT)scanning
of the abdomen and pelvis and preoperative serum CA-125 levels in the management of patients
undergoing surgery for presumed ovarian cancer.
of the abdomen and pelvis and preoperative serum CA-125 levels in the management of patients
undergoing surgery for presumed ovarian cancer.
Inclusion Criteria:
- All patients > 18 years of age undergoing surgery for presumed ovarian, fallopian
tube, or primary peritoneal cancer.
- Patients must be medically and physically able to undergo general anesthesia and
possible tumor debulking.
- Patients must read and sign informed consent form after the nature of the study has
been fully explained.
Exclusion Criteria:
- Presence of clinically significant disease, allergy, or other disorder precluding the
ability to safely perform CT scan of the abdomen and pelvis with oral and intravenous
contrast.
- Vulnerable patients (minors, mentally retarded patients, prisoners, etc.)
We found this trial at
5
sites
Click here to add this to my saved trials
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials